Stephen Chu, PCWG co-chair Russ Leftwich, PCWG co-chair

Slides:



Advertisements
Similar presentations
© 2013 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Advertisements

HSCIC Data Dictionary for Care Modelling Approach Dr. Rahil Qamar Siddiqui Health and Social Care Information Centre, NHS, England.
3/18/19990© 1999, Health Level Seven, Inc. Introduction: Vocabulary domains Marital Status –single (never married) –married –divorced –separated “Vocabulary”
The Nature of Disease.
Utility of Post-Therapy Surveillance Scans in Diffuse Large B-Cell Lymphoma Thompson C et al. Proc ASCO 2013;Abstract 8504.
1 Health Level Seven (HL7) Report Out Population Science and Structured Documents Workgroup (SDWG) Riki Ohira September 22, 2011.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Patient Care WG Care Plan DAM July 31,
© 2013 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Service Oriented Architecture (SOA) Care Coordination Services (CCS) June 05, 2013.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Service Oriented Architecture (SOA) Care Coordination Services (CCS) May 1, 2013.
HL7 SDWG Topic October 29, 2015 David Tao.  HL7 Success! C-CDA 2.1 is cited, and Care Plan is in 2015 Edition Certification Final Rule  Common Clinical.
Substance Abuse James May PH.D. Director SAS Richmond Behavioral Health Authority 2011.
Presented by Allergy/Intolerance/Adverse Reaction Concept Model HL7 Patient Care WG Discussion Pan Canadian Individual Care Standards Collaborative Working.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Patient Care WG Care Plan DAM July 10,
© 2015 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
NICE guidance Generalised Anxiety Disorder Alex Hill.
© 2013 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Characterstic of disease
ICD-10 Updates & review.
C-CDA: Problem/Allergy Problem Status Observation Templates and Clinical Status Updates from Chicago WGM Stephen Chu, PCWG co-chair Russ Leftwich,
QRDA I STU R5 Updates Since pre-ballot content Review
Stephen Joseph Galli, MD  Journal of Allergy and Clinical Immunology 
12 Diagnosing.
Nutrition in HL7 Standards
THE NURSING PROCESS A systematic problem-solving approach used to identify, prevent and treat actual or potential health problems and promote wellness.
Nutrition in HL7 Standards
CLINICAL JUDGMENT Concept 36.
Chapter 15 Evaluating Dr. James Pelletier The Swain Department of Nursing.
Effective Treatment Planning
HL7 WGM Madrid May 2017 Care Plan Standards Update
Clinical Status and related topics update
Clinical Status and related topics update
Drug Abuse.
C-CDA: Problem/Allergy Problem Status Observation Templates and Clinical Status Post Madrid WGM update Stephen Chu, PCWG co-chair Emma Jones,
Patient Care Workgroup Care Plan Topic
Matthew H. Liang, MD Malcolm P. Rogers, MD Ira R. Katz, MD, PhD
Clinical Status and related topics update
HL7 WGM Madrid May 2017 Care Plan Standards Update
Planning for the Integrated Complex Care Case Rate
Clinical Status and related topics update
Clinical Status and related topics update
HL7 Patient Care Work Group
Clinician-on- Stephen Chu September 2016.
Stephen Chu, PCWG co-chair Russ Leftwich, PCWG co-chair
Clinical Status and related topics update
PCWG updates: Care Plan DAM CCS
Condition Resource - Overview
LHS – Care Team Value Sets
PCWG – May 2015 WGM Updates Morning Sessions.
PCWG updates: Part 1 Allergy/Intolerance Care Plan DAM CCS
Patient Care WG Allergy and Intolerances Project
Project Title: Introduction Charts/Graphs/Pictures
Project Title: Introduction Charts/Graphs/Pictures
Cancer results pathway
Mpundu MKC MSc Epidemiology and Biostatistics, BSc Nursing, RM, RN
Roles of the Mental Health Team:
Policy and Procedure Impacts
Concepts of Nursing NUR 212
NIH’S Redefinition of Clinical Trials and Using the New Human Subjects Form Chris Sylvester, M.A. Senior Grant Administrator (AO) Grants and Contracts.
Patient Care Work Group
Stephen Maisto, Professor of Psychology, College of Arts & Sciences, SU “Alcohol and other Substance Use: Treatment, Determinants, and Co-Morbidities”
Patient Care Elaine Ayres, Stephen Chu, Jean Duteau, Laura Heerman Langford, Russ Leftwich, Michael Tan Paris WGM 2015 Monday.
Models of health and health promotion
4. Allergy severity The severity of an allergy is not displayed by the CDA Display Tool, and this is considered relevant to the HP. PT MAJOR The severity.
Epidemiological Designs
Patient Care Elaine Ayres, Stephen Chu,
Patient Care WG Allergy and Intolerances Project
HL7 PCWG: Care Plan, CCS and Health Concern Updates
Lesson 3: Treatment as Prevention
New Provider and Reappointment Training
Presentation transcript:

PCWG – Chicago WGM C-CDA: Problem/Allergy Problem Status Observation Templates Stephen Chu, PCWG co-chair Russ Leftwich, PCWG co-chair Elaine Ayres, PCWG co-chair Laura Heermann Langford, PCWG co-chair Rob Hausam, vocab facilitator Lisa Nelson, PCWG Liaison from SDWG

Allergy Problem Observation in C-CDA 1.1 2/25/2019

Allergy Status Observation in C-CDA 1.1 Table 126: Allergy Status Observation 2/25/2019

Problem Observation in C-CDA 1.1 Health Status Observation: This template represents observations regarding the outcome of care from the interventions used to treat the patient. These observations represent status, at points in time, related to established care plan goals and/or interventions (Contains “Outcome Observation” template) Outcome Observation contains: Act Reference (NEW); Author Participation (NEW); Goal Observation (NEW); Intervention Act (NEW); Progress Toward Goal Observation (NEW) The “Problem Status” Observation uses the same HITSPProblemStatus values 2/25/2019

In C-CDA 2.0 Allergy Status Observation and Problem Status templates are deprecated 2/25/2019

In C-CDA 2.0 Allergy Status Observation and Problem Status templates are deprecated 2/25/2019

Determining Problem status in absence of Allergy Status Observation and Problem Status inadequate for expressing the rich semantics clinical status of the problem or concern statusCode: - metadata Not displayed as human readable data. How is that useful for expressing clinical status? Using “statusCode + effectiveTime to communicate “status”: inadequate 2/25/2019

In C-CDA 2.0 Allergy Status Observation and Problem Status templates are deprecated Determining “Problem Concern Status” in the absence of these templates: The statusCode of the Problem Concern Observation is the definitive indication of the status of the concern Issues Status of the concern = status of the Act (status of workflow) ≠ rich semantics of clinical status of the problem/concern The effectiveTime of the Problem Observation is the definitive indication of whether or not the underlying condition is resolved 2/25/2019

Determining Allergy Status The Allergy Status Observation template has been deprecated in Consolidated CDA Release 2 "Determining a Clinical Statement's Status", i.e. the status of an allergy is determined based on attributes of the Allergy Problem Act and Allergy - Intolerance Observation statusCode + effectiveTime 2/25/2019

Semantics of clinical status: much more complex The status of most clinical problems or conditions (allergy and intolerance included) need to be represented by one of the following values: Active Inactive (semantically different from resolved) Resolved Refuted 2/25/2019

Semantics of clinical status: much more complex Cancer, psychiatric/psychological problems (substances dependencies included) require additional status values: Remission states In remission Partial remission Full/complete remission Early full/partial remission Sustained full/partial remission Relapse states Relapse relapse after partial remission relapse after full remission 2/25/2019

Semantics of clinical status: much more complex The semantic complexity requires the reinstatement of: Problem status template Allergy status observation template Post Chicago WGM communications: From: Russ Leftwich [mailto:cmiotn@gmail.com] Sent: Tuesday, 7 October 2014 11:06 AM To: Stephen Chu; Lisa Nelson; Elaine Ayres Subject: Re: SDWG Agenda Request   A couple of questions.  I don't know that they need to be answered on Thursday, or even asked.  Is recurrence an exact synonym for relapse? Are asymptomatic and clinically undetectable synonyms for inactive?   Russ 2/25/2019

Is recurrence an exact synonym for relapse? From: Stephen Chu Sent: Tuesday, 7 October 2014 11:47 AM To: cmiotn@gmail.com; Lisa Nelson; Elaine Ayres Subject: RE: SDWG Agenda Request   Hi Russ, Is recurrence an exact synonym for relapse? [Stephen: It depends on the context of use. Synonyms of “recurrence” = returning, repeating, reoccurring. In that context, yes, “recurrence” may be considered as a synonym for relapse. “Recurrent” in the context of concepts such as “recurrent pyrogenic cholangitis” is a diagnosis of its own right. One may argue that “pyrogenic cholangitis” with a clinical status = “recurrence” or “relapse” may be treated as synonymous as “recurrent pyrogenic cholangitis”. But I would not use it in that way.] Are asymptomatic and clinically undetectable synonyms for inactive? [Stephen: inactive = quiescent, at rest, state of quietness Remission = disappearance of signs and symptoms of a disease. It may be considered that diseases/problems in inactive state are therefore asymptomatic and clinically undetectable; although the concept of remission (rather than inactive) is used to qualify clinical status of diseases/disorders such as cancer, multiple sclerosis, behavioural disorders) As such, the answer is likely to be these concepts may be considered synonymous, but the context of use will determine which specific concept to be used. Regards, Stephen 2/25/2019